author-photo

Elisa Gremese

Catholic University of the Sacred Heart
The Catholic University of America

326

Papers

3841

Citations

Citation Trend

Filter By

Papers (228) Sort By

Journal Conference Others

Correspondence on Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al ."

2021 Annals of the Rheumatic Diseases
- Elisa Gremese
- Gianfranco Ferraccioli
Show All
- Source
- Cite
- Save
Citations (1)
Reply to: Individuality of the composition of the human microbiota by Fernández-Estupiñán et al.

2021 Clinical and Experimental Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.

2021 Clinical Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.

2021 Clinical and Experimental Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
POS1021 THE PsABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
POS0693 EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS IN REAL-LIFE SETTING: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC, PROSPECTIVE COHORT

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
OP0310 GENDER AND FIBROMYALGIA SEVERITY: REAL LIFE DATA FROM THE ITALIAN REGISTRY

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
An unusual lung involvement in scleroderma: lipoid pneumonia.

2021 Clinical and Experimental Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)